WOOJUNG BIO Inc (215380) — Financial Flexibility Index
WOOJUNG BIO Inc (215380) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of ₩-809.75 Million (operating CF ₩-809.75 Million minus capex ₩0.00) represents 0% of total liabilities (₩65.22 Billion). Also explore WOOJUNG BIO Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
WOOJUNG BIO Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for WOOJUNG BIO Inc across 9 annual periods. Check 215380 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for WOOJUNG BIO Inc (2016–2024)
Year-by-year free cash flow to debt coverage for WOOJUNG BIO Inc. For the full company profile including market capitalisation, see market value of WOOJUNG BIO Inc.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | ₩-816.92 Million | ₩-1.13 Billion | ₩65.33 Billion | ▲ +59.1% |
| 2023 | -0.03x | ₩-2.33 Billion | ₩-3.22 Billion | ₩76.36 Billion | ▼ -114.3% |
| 2022 | 0.21x | ₩13.92 Billion | ₩2.50 Billion | ₩65.28 Billion | ▼ -61.9% |
| 2021 | 0.56x | ₩38.41 Billion | ₩1.73 Billion | ₩68.68 Billion | ▲ +225.0% |
| 2020 | 0.17x | ₩7.19 Billion | ₩-8.57 Billion | ₩41.78 Billion | ▲ +124.9% |
| 2019 | 0.08x | ₩2.37 Billion | ₩208.72 Million | ₩30.97 Billion | ▼ -56.9% |
| 2018 | 0.18x | ₩4.19 Billion | ₩-483.80 Million | ₩23.61 Billion | ▲ +304.0% |
| 2017 | -0.09x | ₩-1.14 Billion | ₩-2.38 Billion | ₩13.07 Billion | ▲ +1.7% |
| 2016 | -0.09x | ₩-126.76 Million | ₩-1.46 Billion | ₩1.43 Billion | — |